Published in PLoS One on August 16, 2010
The chemical basis of pharmacology. Biochemistry (2010) 1.30
Exploring off-targets and off-systems for adverse drug reactions via chemical-protein interactome--clozapine-induced agranulocytosis as a case study. PLoS Comput Biol (2011) 1.26
DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome. Nucleic Acids Res (2011) 1.23
ProBiS-2012: web server and web services for detection of structurally similar binding sites in proteins. Nucleic Acids Res (2012) 1.11
A strategy based on protein-protein interface motifs may help in identifying drug off-targets. J Chem Inf Model (2012) 0.90
Simple Ligand-Receptor Interaction Descriptor (SILIRID) for alignment-free binding site comparison. Comput Struct Biotechnol J (2014) 0.78
Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets. Pharmacol Rev (2017) 0.75
On the Integration of In Silico Drug Design Methods for Drug Repurposing. Front Pharmacol (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
The Protein Data Bank. Nucleic Acids Res (2000) 187.10
The regulation of rabbit skeletal muscle contraction. I. Biochemical studies of the interaction of the tropomyosin-troponin complex with actin and the proteolytic fragments of myosin. J Biol Chem (1971) 35.39
The protein kinase complement of the human genome. Science (2002) 35.36
A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol (2005) 12.22
PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res (2009) 11.05
Predicting new molecular targets for known drugs. Nature (2009) 9.71
Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol (2008) 8.51
Relating protein pharmacology by ligand chemistry. Nat Biotechnol (2007) 6.61
The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structures. J Med Chem (2004) 6.50
Identification of a factor in conventional muscle actin preparations which inhibits actin filament self-association. Biochem Biophys Res Commun (1980) 5.50
Global mapping of pharmacological space. Nat Biotechnol (2006) 4.99
Virtual screening of chemical libraries. Nature (2004) 4.84
Synaptic vesicle phosphoproteins and regulation of synaptic function. Science (1993) 3.93
Towards the optimal screening collection: a synthesis strategy. Angew Chem Int Ed Engl (2008) 3.53
Do structurally similar molecules have similar biological activity? J Med Chem (2002) 3.29
Identifying the proteins to which small-molecule probes and drugs bind in cells. Proc Natl Acad Sci U S A (2009) 2.94
Synapsin dispersion and reclustering during synaptic activity. Nat Neurosci (2001) 2.87
Synapsins: mosaics of shared and individual domains in a family of synaptic vesicle phosphoproteins. Science (1989) 2.61
Synapsin I bundles F-actin in a phosphorylation-dependent manner. Nature (1987) 2.59
Synthesis of natural-product-like molecules with over eighty distinct scaffolds. Angew Chem Int Ed Engl (2009) 2.56
Detecting evolutionary relationships across existing fold space, using sequence order-independent profile-profile alignments. Proc Natl Acad Sci U S A (2008) 2.44
Assessing scoring functions for protein-ligand interactions. J Med Chem (2004) 2.41
Drug discovery using chemical systems biology: repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis. PLoS Comput Biol (2009) 2.35
Recognition of functional sites in protein structures. J Mol Biol (2004) 2.32
Roscovitine targets, protein kinases and pyridoxal kinase. J Biol Chem (2005) 2.31
Ca2+/calmodulin-dependent protein kinase II. Isozymic forms from rat forebrain and cerebellum. J Biol Chem (1985) 2.26
TarFisDock: a web server for identifying drug targets with docking approach. Nucleic Acids Res (2006) 2.26
Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4. J Med Chem (2005) 2.06
Synaptic vesicle mobilization is regulated by distinct synapsin I phosphorylation pathways at different frequencies. Neuron (2003) 2.04
Neurotrophins stimulate phosphorylation of synapsin I by MAP kinase and regulate synapsin I-actin interactions. Proc Natl Acad Sci U S A (1996) 2.01
The synapsins. Annu Rev Cell Biol (1990) 1.97
Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases. J Chem Inf Model (2006) 1.95
PSI-2: structural genomics to cover protein domain family space. Structure (2009) 1.92
PocketPicker: analysis of ligand binding-sites with shape descriptors. Chem Cent J (2007) 1.90
Cellular targets of gefitinib. Cancer Res (2005) 1.87
In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. Br J Pharmacol (2007) 1.77
Chemogenomic approaches to rational drug design. Br J Pharmacol (2007) 1.74
Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule. Proteins (2001) 1.73
Protein kinase inhibitors: contributions from structure to clinical compounds. Q Rev Biophys (2009) 1.72
Synaptic vesicle-associated Ca2+/calmodulin-dependent protein kinase II is a binding protein for synapsin I. Nature (1992) 1.67
Why drugs fail--a study on side effects in new chemical entities. Curr Pharm Des (2005) 1.54
Structural genomics is the largest contributor of novel structural leverage. J Struct Funct Genomics (2009) 1.52
Opposing changes in phosphorylation of specific sites in synapsin I during Ca2+-dependent glutamate release in isolated nerve terminals. J Neurosci (2001) 1.51
sc-PDB: an annotated database of druggable binding sites from the Protein Data Bank. J Chem Inf Model (2006) 1.47
Fold independent structural comparisons of protein-ligand binding sites for exploring functional relationships. J Mol Biol (2005) 1.46
In silico elucidation of the molecular mechanism defining the adverse effect of selective estrogen receptor modulators. PLoS Comput Biol (2007) 1.40
The UniProtKB/Swiss-Prot knowledgebase and its Plant Proteome Annotation Program. J Proteomics (2008) 1.38
Intracellular Targets of Paullones. Identification following affinity purification on immobilized inhibitor. J Biol Chem (2002) 1.34
Characterization of synapsin I fragments produced by cysteine-specific cleavage: a study of their interactions with F-actin. J Cell Biol (1989) 1.28
Synapsin I is structurally similar to ATP-utilizing enzymes. EMBO J (1998) 1.27
Peptide deformylase is a potential target for anti-Helicobacter pylori drugs: reverse docking, enzymatic assay, and X-ray crystallography validation. Protein Sci (2006) 1.25
A protein kinase A-dependent molecular switch in synapsins regulates neurite outgrowth. Nat Neurosci (2002) 1.25
Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors. J Med Chem (2006) 1.23
Dephosphorylated synapsin I anchors synaptic vesicles to actin cytoskeleton: an analysis by videomicroscopy. J Cell Biol (1995) 1.23
PocketMatch: a new algorithm to compare binding sites in protein structures. BMC Bioinformatics (2008) 1.23
Recovering the true targets of specific ligands by virtual screening of the protein data bank. Proteins (2004) 1.20
Alignment-free ultra-high-throughput comparison of druggable protein-ligand binding sites. J Chem Inf Model (2010) 1.20
Structural domains involved in the regulation of transmitter release by synapsins. J Neurosci (2005) 1.19
A multidimensional strategy to detect polypharmacological targets in the absence of structural and sequence homology. PLoS Comput Biol (2010) 1.19
Harvesting candidate genes responsible for serious adverse drug reactions from a chemical-protein interactome. PLoS Comput Biol (2009) 1.18
Ranking targets in structure-based virtual screening of three-dimensional protein libraries: methods and problems. J Chem Inf Model (2008) 1.17
Therapeutic protein kinase inhibitors. Cell Mol Life Sci (2009) 1.16
Protein kinase A-mediated synapsin I phosphorylation is a central modulator of Ca2+-dependent synaptic activity. J Neurosci (2006) 1.15
Computational analysis of ligand relationships within target families. Curr Opin Chem Biol (2008) 1.14
Interaction of free and synaptic vesicle-bound synapsin I with F-actin. Neuron (1992) 1.13
Molecular evolution of the synapsin gene family. J Exp Zool (1999) 1.12
Chemogenomic approaches to drug discovery. Curr Opin Chem Biol (2001) 1.10
Effects of the neuronal phosphoprotein synapsin I on actin polymerization. I. Evidence for a phosphorylation-dependent nucleating effect. J Biol Chem (1992) 1.04
Phosphorylation of synapsin I by cAMP-dependent protein kinase controls synaptic vesicle dynamics in developing neurons. J Neurosci (2005) 1.04
Synapsin III, a novel synapsin with an unusual regulation by Ca2+. J Biol Chem (1998) 1.03
SAR index: quantifying the nature of structure-activity relationships. J Med Chem (2007) 1.01
Synapsins I and II are ATP-binding proteins with differential Ca2+ regulation. J Biol Chem (1998) 1.00
A simple and fuzzy method to align and compare druggable ligand-binding sites. Proteins (2008) 0.99
Inverse in silico screening for identification of kinase inhibitor targets. Chem Biol (2007) 0.98
Vesicle pools and synapsins: new insights into old enigmas. Brain Cell Biol (2007) 0.97
GPCR antitarget modeling: pharmacophore models for biogenic amine binding GPCRs to avoid GPCR-mediated side effects. Chembiochem (2005) 0.96
Homo- and heterodimerization of synapsins. J Biol Chem (1999) 0.94
Model structure of APOBEC3C reveals a binding pocket modulating ribonucleic acid interaction required for encapsidation. Proc Natl Acad Sci U S A (2009) 0.94
Crystal structure of pyridoxal kinase in complex with roscovitine and derivatives. J Biol Chem (2005) 0.93
In silico-guided target identification of a scaffold-focused library: 1,3,5-triazepan-2,6-diones as novel phospholipase A2 inhibitors. J Med Chem (2006) 0.92
Ligand-based approach to in silico pharmacology: nuclear receptor profiling. J Chem Inf Model (2006) 0.87
Similarity in drugs: reflections on analogue design. Drug Discov Today (2006) 0.87
Synapsin phosphorylation by SRC tyrosine kinase enhances SRC activity in synaptic vesicles. J Biol Chem (2007) 0.85
Tetramerization and ATP binding by a protein comprising the A, B, and C domains of rat synapsin I. J Biol Chem (2003) 0.81
Synapsin I is phosphorylated at Ser603 by p21-activated kinases (PAKs) in vitro and in PC12 cells stimulated with bradykinin. J Biol Chem (2002) 0.81
Target specificity and off-target effects as determinants of cancer drug efficacy. Expert Opin Drug Metab Toxicol (2008) 0.81
Prediction of sub-cavity binding preferences using an adaptive physicochemical structure representation. Bioinformatics (2009) 0.79
Reverse pharmacognosy: application of selnergy, a new tool for lead discovery. The example of epsilon-viniferin. Curr Drug Discov Technol (2005) 0.78
Synapsin associates with cyclophilin B in an ATP- and cyclosporin A-dependent manner. J Neurochem (2005) 0.78
Sound-driven synaptic inhibition in primary visual cortex. Neuron (2012) 2.84
Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice. J Clin Invest (2011) 2.25
Comparative evaluation of eight docking tools for docking and virtual screening accuracy. Proteins (2004) 2.12
Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets? Proteins (2003) 1.93
Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling. J Clin Invest (2012) 1.87
Optimizing fragment and scaffold docking by use of molecular interaction fingerprints. J Chem Inf Model (2007) 1.87
Selective structure-based virtual screening for full and partial agonists of the beta2 adrenergic receptor. J Med Chem (2008) 1.59
Synaptophysin: leading actor or walk-on role in synaptic vesicle exocytosis? Bioessays (2004) 1.55
Overlapping role of dynamin isoforms in synaptic vesicle endocytosis. Neuron (2011) 1.49
A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors. Proteins (2006) 1.48
sc-PDB: an annotated database of druggable binding sites from the Protein Data Bank. J Chem Inf Model (2006) 1.47
sc-PDB: a database for identifying variations and multiplicity of 'druggable' binding sites in proteins. Bioinformatics (2011) 1.46
TBC1D24, an ARF6-interacting protein, is mutated in familial infantile myoclonic epilepsy. Am J Hum Genet (2010) 1.44
Phosphatidylinositol 4-kinase type IIalpha is responsible for the phosphatidylinositol 4-kinase activity associated with synaptic vesicles. Proc Natl Acad Sci U S A (2003) 1.28
Neuronal nitric-oxide synthase localization mediated by a ternary complex with synapsin and CAPON. Proc Natl Acad Sci U S A (2002) 1.27
Allosteric model of maraviroc binding to CC chemokine receptor 5 (CCR5). J Biol Chem (2011) 1.25
Lack of synapsin I reduces the readily releasable pool of synaptic vesicles at central inhibitory synapses. J Neurosci (2007) 1.25
Phosphorylation of spinophilin modulates its interaction with actin filaments. J Biol Chem (2002) 1.23
Synapsin I is an oligomannose-carrying glycoprotein, acts as an oligomannose-binding lectin, and promotes neurite outgrowth and neuronal survival when released via glia-derived exosomes. J Neurosci (2011) 1.23
SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function. Hum Mol Genet (2011) 1.23
Remote control of induced dopaminergic neurons in parkinsonian rats. J Clin Invest (2014) 1.23
Protein sorting in the synaptic vesicle life cycle. Prog Neurobiol (2006) 1.23
Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening. J Med Chem (2007) 1.23
Delineating a Ca2+ binding pocket within the venus flytrap module of the human calcium-sensing receptor. J Biol Chem (2005) 1.22
Molecular modeling of the second extracellular loop of G-protein coupled receptors and its implication on structure-based virtual screening. Proteins (2008) 1.20
Recovering the true targets of specific ligands by virtual screening of the protein data bank. Proteins (2004) 1.20
Alignment-free ultra-high-throughput comparison of druggable protein-ligand binding sites. J Chem Inf Model (2010) 1.20
Structural domains involved in the regulation of transmitter release by synapsins. J Neurosci (2005) 1.19
Modeling and mutagenesis of the binding site of Calhex 231, a novel negative allosteric modulator of the extracellular Ca(2+)-sensing receptor. J Biol Chem (2003) 1.19
Positive and negative allosteric modulators of the Ca2+-sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain. J Biol Chem (2004) 1.19
Dynamin phosphorylation controls optimization of endocytosis for brief action potential bursts. Elife (2013) 1.19
Ranking targets in structure-based virtual screening of three-dimensional protein libraries: methods and problems. J Chem Inf Model (2008) 1.17
Opposite changes in glutamatergic and GABAergic transmission underlie the diffuse hyperexcitability of synapsin I-deficient cortical networks. Cereb Cortex (2008) 1.17
Functional characterization of sonic hedgehog mutations associated with holoprosencephaly. J Biol Chem (2004) 1.16
Acute stress increases depolarization-evoked glutamate release in the rat prefrontal/frontal cortex: the dampening action of antidepressants. PLoS One (2010) 1.16
Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease. J Neurosci (2012) 1.16
Protein kinase A-mediated synapsin I phosphorylation is a central modulator of Ca2+-dependent synaptic activity. J Neurosci (2006) 1.15
Synapsin-I- and synapsin-II-null mice display an increased age-dependent cognitive impairment. J Cell Sci (2008) 1.14
Novel compound heterozygous mutations in TBC1D24 cause familial malignant migrating partial seizures of infancy. Hum Mutat (2013) 1.13
Communication breaks-Down: from neurodevelopment defects to cognitive disabilities in Down syndrome. Prog Neurobiol (2010) 1.13
Synaptophysin I controls the targeting of VAMP2/synaptobrevin II to synaptic vesicles. Mol Biol Cell (2003) 1.13
Simultaneous two-photon imaging and photo-stimulation with structured light illumination. Opt Express (2010) 1.12
Using the atomic force microscope to study the interaction between two solid supported lipid bilayers and the influence of synapsin I. Biophys J (2004) 1.11
Dynamic interaction of amphiphysin with N-WASP regulates actin assembly. J Biol Chem (2009) 1.10
Lithium rescues synaptic plasticity and memory in Down syndrome mice. J Clin Invest (2012) 1.07
The role of synapsins in neuronal development. Cell Mol Life Sci (2009) 1.07
Classification framework for graphene-based materials. Angew Chem Int Ed Engl (2014) 1.06
Customizing G Protein-coupled receptor models for structure-based virtual screening. Curr Pharm Des (2009) 1.06
Identification of a developmentally regulated pathway of membrane retrieval in neuronal growth cones. J Cell Sci (2008) 1.06
Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor. Mol Pharmacol (2011) 1.05
Phosphorylation of synapsin I by cAMP-dependent protein kinase controls synaptic vesicle dynamics in developing neurons. J Neurosci (2005) 1.04
Molecular determinants of non-competitive antagonist binding to the mouse GPRC6A receptor. Cell Calcium (2009) 1.03
High-throughput modeling of human G-protein coupled receptors: amino acid sequence alignment, three-dimensional model building, and receptor library screening. J Chem Inf Comput Sci (2004) 1.03
Structure-based discovery of allosteric modulators of two related class B G-protein-coupled receptors. ChemMedChem (2011) 1.02
Assessing the scaffold diversity of screening libraries. J Chem Inf Model (2006) 1.02
ERK activation in axonal varicosities modulates presynaptic plasticity in the CA3 region of the hippocampus through synapsin I. Proc Natl Acad Sci U S A (2009) 1.02
Synapsin II desynchronizes neurotransmitter release at inhibitory synapses by interacting with presynaptic calcium channels. Nat Commun (2013) 1.01
TBC1D24 regulates neuronal migration and maturation through modulation of the ARF6-dependent pathway. Proc Natl Acad Sci U S A (2014) 1.01
Development and validation of a novel protein-ligand fingerprint to mine chemogenomic space: application to G protein-coupled receptors and their ligands. J Chem Inf Model (2009) 0.99
Strategies to maximize the performance of a STED microscope. Opt Express (2012) 0.99
A simple and fuzzy method to align and compare druggable ligand-binding sites. Proteins (2008) 0.99
Nanostructured superhydrophobic substrates trigger the development of 3D neuronal networks. Small (2012) 0.98
Regulated delivery of AMPA receptor subunits to the presynaptic membrane. EMBO J (2003) 0.98
Autism-related behavioral abnormalities in synapsin knockout mice. Behav Brain Res (2012) 0.98
Emergent functional properties of neuronal networks with controlled topology. PLoS One (2012) 0.97
A hybrid bioorganic interface for neuronal photoactivation. Nat Commun (2011) 0.96
Protein-ligand-based pharmacophores: generation and utility assessment in computational ligand profiling. J Chem Inf Model (2012) 0.96
SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance. Nat Neurosci (2012) 0.96
Synapsin is a novel Rab3 effector protein on small synaptic vesicles. II. Functional effects of the Rab3A-synapsin I interaction. J Biol Chem (2004) 0.96
Fluorescence resonance energy transfer detection of synaptophysin I and vesicle-associated membrane protein 2 interactions during exocytosis from single live synapses. Mol Biol Cell (2002) 0.95
MAPK/Erk-dependent phosphorylation of synapsin mediates formation of functional synapses and short-term homosynaptic plasticity. J Cell Sci (2010) 0.95
Site-specific synapsin I phosphorylation participates in the expression of post-tetanic potentiation and its enhancement by BDNF. J Neurosci (2012) 0.95
Kidins220/ARMS as a functional mediator of multiple receptor signalling pathways. J Cell Sci (2012) 0.95
Structural insights into the molecular basis of the ligand promiscuity. J Chem Inf Model (2012) 0.95
Comparison and druggability prediction of protein-ligand binding sites from pharmacophore-annotated cavity shapes. J Chem Inf Model (2012) 0.95
Reduced release probability prevents vesicle depletion and transmission failure at dynamin mutant synapses. Proc Natl Acad Sci U S A (2012) 0.94
N1-Benzoyl-N2-[1-(1-naphthyl)ethyl]-trans-1,2-diaminocyclohexanes: Development of 4-chlorophenylcarboxamide (calhex 231) as a new calcium sensing receptor ligand demonstrating potent calcilytic activity. J Med Chem (2006) 0.94
Cognitive impairment in Gdi1-deficient mice is associated with altered synaptic vesicle pools and short-term synaptic plasticity, and can be corrected by appropriate learning training. Hum Mol Genet (2008) 0.94
The synapsin gene family in basal chordates: evolutionary perspectives in metazoans. BMC Evol Biol (2010) 0.94
Abnormal exocytotic release of glutamate in a mouse model of amyotrophic lateral sclerosis. J Neurochem (2011) 0.94
Intracellular chloride concentration influences the GABAA receptor subunit composition. Nat Commun (2012) 0.93
In silico-guided target identification of a scaffold-focused library: 1,3,5-triazepan-2,6-diones as novel phospholipase A2 inhibitors. J Med Chem (2006) 0.92
Replica-moulded polydimethylsiloxane culture vessel lids attenuate osmotic drift in long-term cell cultures. J Biosci (2009) 0.92
Hot-spots-guided receptor-based pharmacophores (HS-Pharm): a knowledge-based approach to identify ligand-anchoring atoms in protein cavities and prioritize structure-based pharmacophores. J Chem Inf Model (2008) 0.92
Flexible, all-polymer microelectrode arrays for the capture of cardiac and neuronal signals. Biomaterials (2010) 0.92
Phosphorylation of synapsin domain A is required for post-tetanic potentiation. J Cell Sci (2007) 0.91
VGLUT1 and VGAT are sorted to the same population of synaptic vesicles in subsets of cortical axon terminals. J Neurochem (2009) 0.90
Tyrosine phosphorylation of synapsin I by Src regulates synaptic-vesicle trafficking. J Cell Sci (2010) 0.90
Estrogen receptor alpha as a key target of red wine polyphenols action on the endothelium. PLoS One (2010) 0.90